News

Zurich - Zurich-based researchers working with an international team have discovered that neural prostheses communicate more effectively with the brain via natural signals than with the conventionally used time-constant stimulation of the sciatic nerve. These findings could be used to give amputees greater confidence in their prosthesis.

Zurich - This spring, Agroscope will launch a field trial with spring barley in which genetic scissors will be used to disable a certain gene. The aim here is to demonstrate whether these mutations lead to an increased yield. The Federal Office for the Environment has approved the experiment on Agroscope's protected site subject to certain conditions.

Zurich - The Swiss Federal Institute of Technology in Zurich (ETH) is heading up an initiative for the domestic production of chips. The program aims to strengthen Switzerland’s self-sufficiency in the face of competition from the European and US markets.

Zurich/Copenhagen/Helsinki - Solita, the Finnish data analysis and strategic consulting firm, is opening an office in Zurich under its Danish brand Intellishore. Intellishore specializes in addressing complex data and strategy problems for multinational companies, particularly those operating in the life sciences sector.

In times of increased uncertainty, the Greater Zurich Area continues to stand tall as a stable business location: the fDi Report 2024 ranks the Swiss region as one of the leading European destinations for international companies.

Schlieren - Cutiss has published the results of a one-year study on its skin alternative denovoSkin. The data from the Phase 2 clinical trial in adult and adolescent severe burn patients are positive.

Zurich - Wingman Ventures has rebranded and is now called Founderful. The venture capital firm, which focuses on robotics and industrial pre-seed startups, has already raised $85 million for its new Fund II. It is aiming to close $120 million in the next few months.

Horgen/San Francisco - Navignostics, a spin-off from the University of Zurich, will in future be using the imaging system developed by Standard BioTools from San Francisco to determine personalized cancer therapies. Together, the two partners are seeking to advance imaging mass cytometry.

Wallisellen/Vancouver/Baar - ScanDiags, a specialist in the field of medical imaging, has entered into a partnership with OMNIA Global. The financial services provider will support business development, financing and market development activities.